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Tissues from normal human skin and various skin diseases 
we~e studied with the immunoperoxidase technique using an 
hntlbody to adult T-cell leukemia-derived factor (ADF), a 
omologue of human thioredoxin. Normal human skin 
showed positive immunostaining for ADF/thioredoxin in 
the Outer root sheath of hair follicle, sebaceous glands, and 
secreting components of apocrine and eccrine sweat units, 
but not in the unexposed interfollicular epidermis and other 
p.a~ts of both hair follicles and the sweat units. Immunoreac-
tiVity of benign skin tumors gave similar distribution to their 
n?rmal counterparts; trichilemmal cyst, nevus sebaceus, se-
nile sebaceous hyperplasia, and mixed cell tumor were posi-
tive for immunostaining, whereas epidermal cyst and pilo-
matricoma were not. No immunoreactivity was detected in 
malignant skin tumors such as basal cell carcinoma and 
poorly differentiated squamous cell carcinoma. Solar kerato-
sis, well-differentiated squamous cell carcinoma, some of 
metastatic lesions of squamous cell carcinoma, and extra-
mammary Paget's disease reacted with the antibody. These 
immunoreactivities reflected numerous functions of thiore-
doxin in higher organisms. Our findings suggest that the 
expression of ADF/thioredoxin in both normal and abnor-
mal human skin is related to epithelial cell differentiation. ] 
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T hioredoxin, identified originally in Escherichia coli as an electron donor for ribonucleotide reductase [1], is widely distributed among mammals and possesses dithiol-disulfide oxidoreductase activity [2] . Its active site has strong homology with protein disulfide iso-
~e] rase tha~ catalyzes the refolding of disulfide-containing proteins 
h' and with phosphoinositide-specific phospholipase C [4]. In tgher organisms the thioredoxin system that includes NADPH as a 
e fectron donor, thioredoxin reductase, and thioredoxin has a variety 
o f ~unct~ons such as maintenance of protein synthesis [5], regulation 
o Illsullll activity [6] , activation of glucocorticoid receptors [7], 
processes of lymphocyte infiltration/inflammation in relation to 
Y-Illterferon action and biosynthesis of pteridines [8]. Immunohis-
tochemical analysis revealing the wide distribution of thioredoxin lila . . 
vanety of organs in adult rats also suggests a broader role for thiS 
protein [9]. 
~du~t T-cell leukemia (ATL) , initially reported in Japan as an 
en emlC leukemia [10]' is known for its close association with 
-----------------------------------------------19~~nuscript received June 14, 1991; accepted for publication March 3, 
rn~eprint requests to: Hisashi Wakita, Department of Dermatology, Ha-
43~3atsu University School of Medicine, 3600 Handa-cho, Hamamatsu 
I,Japan. 
Abbreviations: 
ADF: ATL-derived factor 
ATL: adult T-cell leukemia 
~GTP: y-glutamyl transpeptidase 
ILTLV-1: human T-lymphotropic virus-l 
-2: Interleukin 2 
SCC: squamous cell carcinoma 
human T-lymphotropic virus-l (HTLV-l) infection [11]. Tumor 
cells of ATL express abnormally high levels of interleukin-2 (IL-2) 
receptors [12] without significant production oflL-2 that is respon-
sible for the high induction ofIL-2 receptors [13]. It is assumed that 
the enhanced expression of IL-2 receptors on HTL V -1 - infected 
T-cell lines is maintained by ATL-derived factor (ADF), a protein 
produced by these cell lines [14-16] . Cloning of complementary 
DNA shows that human ADF has a close homology with human 
thioredoxin [17,18]. Both proteins consist of 105 amino acids with 
theoretical molecular weights of approximately 12,000 (including 
the initial methionine) , except for difference in two amino acid 
residues [17 -19]. Recombinant (r) ADF has a sequence identical to 
the active enzymatic site of thioredoxin (-Cys-Gly-Pro-Cys-) and, 
in fact, thioredoxin-like activities such as the degradation of insulin 
[20] . Thus, ADF is supposed to be a member of the human thiore-
doxin family [17,19-21]. -
Human skin contains high levels of thioredoxin reductase and 
thioredoxin, especially in differentiated human keratinocytes [22] 
and melanocytes [23]. By using polyclonal antibodies against ADF 
raised in rabbits, we undertook the immunohistochemical analysis 
on the distribution of ADF/thioredoxin in normal and abnormal 
human skin tissues. 
MATERIALS AND METHODS 
Tissues Tissues were taken at surgical operations and biopsies. 
The objectives are summarized in Tables I and II with the results of 
staining. As normal human skin, we used clinically normal-
. appearing skin in the vicinity of benign solitary tumors on the 
non - sun-exposed area. 
Antibody Preparation Rabbit heteroantibodies recognizing 
ADF were raised in our laboratory by immunization of rabbits with 
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Table I. Immunoperoxidase Staining of Normal Human Skin" 
Results of Immunostaining 
Epidermis 
Philosebaceous follicle 
Outer root sheath 
Infundibulum 
Isthmus 
Inferior portion 
Inner root sheath 
Hair matrix 
Sebaceous gland 
Apocrine and eccrine sweat units 
Gland 
Duct 
Anagen 
(-) 
(+) 
(-) 
(-) 
(-) 
(-) 
(+) 
(+) 
(-) 
Catagen 
(-) 
(+) 
(+) 
• Parentheses indicate staining scored on a scale of either (-), negative or (+), posi-
tive. 
a 28-mer synthetic peptide corresponding to the C-term.inal se-
quence of ADF protein as described in detail in [15]. The synthetic 
oligopeptide of ADF was conjugated to bovine serum albumin 
(BSA) and injected subcutaneously into rabbits. After immunizing 
three times, sera from rabbits were purified by saturated ammonium 
sulfate precipitation and then dialyzed against phosphate-buffered 
saline (PBS: 10 mmol/l sodium phosphate, 133 mmoljl sodium 
chloride, pH 7.4), followed by application to BSA-Sepharose 
(Sigma, St. Louis, MO) to remove anti-BSA components . Then the 
purification by using Sepharose CL-4B (Sigma) coupled with the 
ADF C-terminal peptide and dialysis against PBS were performed, 
successi vely. 
Western Blot Analysis . Western blot analysis was carried out by 
the method of Towbin et al [24]. In brief, rADF (5 ng/lane), pro-
duced by the method previously described [20], was electrophoresed 
on 15% sodium dodecyl sulfate polyacrylamide gels under reduced 
conditions. After electro-transfer to a polyvinylidene difluoride 
membrane (Millipore, Bedford, MA) under a constant current of 
200 rnA, non-specific reaction was blocked with 10% skim milk 
(Difco, Detroit, MI) and 10% fetal calf serum (Cell Culture Labora-
tory, Cleveland, OH). The membrane was incubated with the 
affinity-purified rabbit anti-ADF antibody or rabbit control IgG, 
and then with biotinylated anti-rabbit IgG (Vector Laboratory, 
Burlingame, CA). For cold inhibition aliquots of the antibody were 
pre incubated with various volumes of rADF. The bands reactive 
with the antibodies were visualized after incubation with the 
avidin-alkalinephosphatase complex and its substrate. As shown in 
Fig 1, the purified antibodies recognized rADF with relative molec-
ular weight 13 kD on Western blots, and the immunoreactivity was 
dose-dependently inhibited by preincubation with rADF. 
Immunostaining Tissues were fixed in formalin and embedded 
in paraffin. Four-micrometer- thick sections were deparaffinized in 
xylene and were stained using standard peroxidase-antiperoxidase 
immunostaining method. Endogeneous peroxidase activity was 
blocked in 3% H 20 2 methanol. After treating with PBS containing 
10% normal swine serum to reduce nonspecific staining, the sec-
tions were incubated with a primary antibody (2 f1g/ml) fo llowed 
by washing with PBS, and were reacted with swine anti-rabbit 
serum and then incubated with the peroxidase-anti peroxidase 
complex. Development was performed adding 3-amino-9-
ethylcarbazole solution with a 0.01 % aqueous solution of H 20 2 . 
The sections were then counter-stained in Mayer hematoxylin. 
Control Dendritic cells in lymphoid organs are known to have 
positive immunoreactivity and some of infiltrating histiocytes and 
lymphocytes in several cutaneous diseases were positively stained in 
preliminary staining (Fig 2). Then, these cells that were positively 
stained in our preparations served as positive control. As negative 
control, normal rabbit serum was used instead of the anti-ADF 
antibody. 
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Figure 1. Western blot analysis of rADF with purified anti-ADF antibOd-
ies. Cold inhibition by rADF was performed. rADF (5 ng/lane) was electro-
phoresed. After the blotting step, the membrane was incubated with 0.35 
J.lg/ml anti-C terminal ADF antibody (anti-ADF Ab) or control rabbit IgG 
(control Ab). Aliquots of the antibody were preincubated with 20 or 200 flg 
of rADF. . 
RESULTS 
Well-preserved tissues and cells under adequate fixation conditions 
show th e distribution of thioredoxin reductase and thioredoxin on 
plasma membranes and in periplasmic spaces [9,23]. In the present 
study, however, we used formalin-fixed and paraffin-embedded 
sections. Because the antigenicity of ADF in cell membranes was 
not preserved by this procedure, we evaluated the cytosomal stain-
ing pattern. 
Table II. Immunoperoxidase Staining of Epithelial and 
Epidermal Components in Cutaneous Diseases 
--------~----------~--------------------------------
Intensity of Stain~ 
Cutaneous Diseases + +-+ 
-----------------------------------------------------
Benign tumors and nevus 
Epidermal cyst 
Trichi lemmal cyst 
Senile sebaceous hyperplasia 
Nevus sebaceus 
Seborrheic keratos is 
Steatocystoma multiplex 
Pilomatricoma 
Eccrine poroma 
Mixed cell tumor 
Premalignant tumors and carcinoma in situ 
Solar keratosis 
Bowen's disease 
Malignant tumors 
Squamous cell carcinoma 
3b 
o 
o 
o 
2 
o 
2 
1 
o 
o 
o 
o 
o 
2 
2 
5 
2 
o 
o 
1 
9 
o 
Well differentiated 0 0 
Poorly differentiated 21 1 
Metastatic lesion 4 2 
Basal cell epithelioma 4 0 
Extramammary Paget's disease 0 2 
o 
3 
o 
o 
o 
o 
o 
o 
o 
o 
z 
1 
o 
o 
o 
o 
o Eccrine porocarcinoma 1 0 
---------------------------------------------------
• Staining scored on a scale of - (negative), + (positive), and ++ (strongly positive). 
• Number of cases. 
VOL. 99, NO.1 JULY 1992 
Figure 2. Positive control. A few of mononuclear cells in the dermal infil-
trate of squamous cell carcinoma show strong immunoreactivity in their 
cytoplasm and nuclei. Magnification X 400. Bar, 10 Ji.m. 
NO~tnal Skin Immunoreactivity in normal human skin was sum-
manzed in Table 1. Sun-unexposed epidermis showed no immuno-
reactivity in all layers, whereas normal-appearing squamous cells of 
bun-exposed skin were positively stained (Fig 3). In the pilose-
hceous follicl e, intermediate layers in the isthmus of the outer root 
s eath (Fig 4a) and the inferior portion of follicles at the catagen 
p( hase (Fig 4b) and the cytoplasm and nuclei of sebaceous gland cells 
bFlg 4c) gave positive staining. In these positive areas (except se-
aceous glands) nuclear staining was faint or negligible, whereas the 
croplasm was stained intensely . Neither the hair matrix, inner root 
s eath, nor infundibular portion of the outer root sheath showed 
Immunoreactivity. Secreting cells both of the apocrine (Fig 5a) and 
~cnne sweat units (Fig 5b) showed positive cytoplasmic staining. 
n the other hand, no immunoreactivity was detected in the ductal 
POrtion of these sweat units. 
Btnign Tumors and Nevus Table II shows immunoreactivity 
o several cutaneous benign tumors. Almost similar immunostain-~~l b~tween benign skin tumors and their counterparts in the nor-
. tls~ues were observed. In epidermal cysts, the cytoplasm of 
?lthehal cells in the cystic walls showed negative immunostaining. 
t~ tnchdemmal cysts, squamoid cells with trichilemmal keratiniza-
Ion showed intense cytoplasmic staining, but basaloid cells at outer-
~ftt layer~ gave no staining (Fig 6a). Only a few fat-containing 
s 111 se l11le sebaceous hyperplasia and nevus sebaceous showed a 
PositIVe staining pattern as observed in normal sebaceous glands. 
F' c;~ouri 3. Immunostaining of interfollicular sun-exposed epidermis. The 
nificso. of kerat1l1ocytes in stratum Malpighii shows positive reaction. Mag-
atiOn X 100. Bar, 50 Ji.m. 
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Although basaloid cells were not immunostained, squamous differ-
entiating cells in seborrheic keratosis, such as lining cells of dilated 
hair follicles, were reactive with the antibody (Fig 6b). Cystic walls 
of steatocystoma multiplex, except the sebaceous portion that 
showed similar immunoreactivity to normal sebaceous glands, and 
all components of pilomatricoma that included basophilic, transi-
tional, and shadow cells gave negative immunostaining. Although 
eccrine poroma were negative for immunostaining, tubular differ-
entiating cells of mixed cell tumor were positively stained. 
,. 
H 
a 
~' -" .,,:. 
Figure 4. Immunostaining of pilosebaceous unit. Intermediate layers in the 
isthmus of outer root sheath of a hair follicle (0, magnification X 260), cells 
in the outer root sheath of a catagen hair fo llicle (b, magnification X 65), 
sebaceous cells (c, magnification X 130) arc positively stained. In (b) , inner 
root sheath and matrix ce lls already disappear. In (c), lipid droplets arc not 
stained. D, dermis; H, hair. Bars: a, 10 Ji.111; b, 50 Ji.m; c, 25 Ji.m. 
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Figure 5. Immunostaining of sweat units. Secreting cells of apocrine (a) and eccrine (b, arrow) glands are positively stained. Ductal portions of eccrine 
glands are not reactive (b, arrowheads). Magnification X 400. Bar, 10 11m. 
Premalignant Tumors and Carcinomas In Situ Squamous 
cells in mid-epidermal portions of solar keratosis showed positive 
immunostaining with no immunoreactivity in either basaloid cells 
in one to two layers above the basement membrane or cells contain-
ing keratohyaline granules (Fig 7a). Bowen's diseases showed 
unique immunostaining pattern. Despite weak and focal reactivity 
in apparently cancerous portions that lost normal polarity of the 
epidermal architecture and were poorly differentiated, in the vicin-
ity of these areas the acanthotic epidermis with preserved polarity 
showed diffuse and intense immunostaining (Fig 7b). 
Invasive Carcinomas Staining patterns demonstrated a striking 
contrast among the well-differentiated, poorly differentiated, and 
metastatic types of squamous cell carcinomas (SeC). In well-
differentiated sec, cells in differentiated portions showed strong 
immunoreactivity, whereas those in less differentiated portions 
Figure 6. Immunostaining of cutaneous benign tumors. Squamous cells showing trichilemmal keratinization in trichilemmal cyst (a) and squamous cells 
lining a dilated hair follicle in seborrheic keratosis (b) show positive staining. In (b), basaloid cells are negative. D, dermis. Magnification X 100. Bar, 50 J.lIU. 
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Figure 7. Immunostaining of cutaneous premalignant tumors and carcino-
rna~ In ~itu. In solar keratosis (a, magnification X 100), squamous cells of the 
~I ~epldermis show positive staining, whereas basaloid cells and cells con-t nmg keratohyaline granules are not stained. In Bowen's disease (b, magni-
wChtlon X200), cancerous portions (arrows) give weak and focal staining, 
dereas epidermis in the vicinity of these areas (arrowheads) shows diffuse 
an Intense staining. Bars: a, 50 lim; b, 25 lim. 
Were .negative (Fig 8a). Cells in poorly differentiated SCC gave 
negative immunoreactivity. Of six cases with metastatic SCC, two 
~ases. showed positive immunoreactivity in all tumor cells (Fig 8b) 
esplte negative staining in the primary lesions. Large round cells of 
extramammary Paget's diseases invading among ADF-negative 
normal epithelial components such as eccrine sweat ducts showed ~OSltlve immunostaining. Neither basal cell epithelioma nor ec-
fine por' . . . . II ocarcmoma gave ImmunoreactiVity m tumor ce s. 
DISCUSSION 
Xhelresent study describes immunoperoxidase staining analysis on 
a ~ IstnbutlOn of ADF-associated antigen in normal human skm 
pnl several cutaneous diseases by using an affinity-purified rabbit A~Fclonal antibody against the C~terminal ~8 mer sequen~e ?f 
both ' ?ur results showed lar~e vanatlons o~ Immunoreactivity m 
h different cell types and diseases. Negative immunoreactivity, A~;ever, does not necessarily mean absence of the expression of 
bel /thlOredoxin. Rather, the amount of this protein seems to be 
im ow the detectable level with our method. For example, positive 
an:~noreactivity was found in the ~ndotheli~1 cells in snap-frozen 
emb ~n-fixed speCimens, but not m formalm-fixed and paraffin-
ing \ ded ones (data not shown). Despite such limitation in analyz-
prot t. e results, the present immunostaining reflects the relative 
AD;~n leveL The strong expression suggests the participation of 
In phYSIOlogic and pathologic processes in human skin tissues. 
ADF/THIOREDOXIN IN EPITHELIUM 105 
Figure 8. Immunostaining of malignant tumors. In sec, squamoid cells in 
the well-differentiated portion of tumor islands (a) and poorly differentiated 
cells in a metastatic lesion (b) show positive staining. In (a), poorly differen-
tiated cancer cells at the periphery are negatively stained. Magnification 
X 100. Bar, 50 lim. 
Wide but characteristic distribution of ADF /thioredoxin in normal 
and pathologic human skins has confirmed studies by Rozell et al [9] 
and Hansson et al [23] showing various functions of thioredoxin in 
higher organisms such as protein synthesis, intracellular transport, 
and different forms of secretion. ~ 
ADF/thioredoxin was expressed in trichilemmal keratinizing 
cells, and hyperplastic and highly keratinizing cells of cutaneous 
tumors. During the growing phase of hair follicles, ADF /thiore-
doxin was present in the isthmus of outer root sheath with trichi-
lemmal keratinization but was absent in highly proliferative parts of 
the outer root sheath and matrix cells. In the involutional phase of 
hair cycle, the expression of ADF/thioredoxin was confined to the 
inferior portion of outer root sheath that finished proliferation and 
started trichilemmal keratinization. Such unique localization sug-
gests that ADF /thioredoxin participates in trichilemmal keratiniza-
tion by limiting proliferation and promoting differentiation of the 
inferior portion of outer root sheath. On the other hand, no reactiv-
ity was detected in highly proliferative cells in both normal and 
abnormal cutaneous elements such as basal cells of interfollicular 
epidermis, matrix cells in the germinative hair bulb, peripheral por-
tion of well-differentiated and poorly differentiated SCC. Different 
reactivity patterns observed in original and metastatic SCC were 
associated to the degree of differentiation and proliferation of tumor 
cells. Of note is a recent finding on thioredoxin as a mediator of 
growth-inhibitory signal [25]. Therefore, one of the predominant 
roles of ADF /thioredoxin in the skin relates to the differentiation, 
but not proliferation, process. 
106 WAKITA ET AL 
In living cells of epidermis the reduction of intracellular environ-
ment is required to keep keratins from cross-linking by the forma-
tion of disulfide bonds. Because the thioredoxin system functions as 
reducing agents, it is likely that ADF/thioredoxin prevents prema-
ture insolublization and aggregation of keratin proteins that may 
adversely influence tissue integration [26]. Large amounts of ADF / 
thioredoxin may be necessary in trichilemmal keratinizing cells that 
produce keratins without the formation of keratohyaline granules, 
and highly keratinizing tumor cells. 
In secreting systems, apocrine, eccrine, and sebaceous glands were 
positively stained. Analyses in adult rats reveal that thioredoxin is 
uniformly distributed in secretory cells of salivary glands, sweat 
glands, adrenal glands, parietal cells in the stomach, and both exo-
crine and endocrine cells in pancreas [9] . Based on the fact that 
secretory process involves sulfhydryl groups [27 - 31 J, thioredoxin 
has been suspected to playa role in the secretion [2,31,32]. 
y-glutamyl transpeptidase (Y-GTP) [27 - 29] is a crucial element 
of glutaredoxin system that plays a role complementary to the thio-
redoxin system in the intracellular reduction mechanism [2] . The 
localization of y-GTP in the skin was similar to that of ADF /thior-
edoxin. y-GTP is detected in differentiating skin appendages and 
well-differentiated SCC but not in normal epidermis or poorly dif-
ferentiated SCC [34,35]. 
Normal-appearing epidermis of the exposed area, but not the 
unexposed normal epidermis, invariably expressed ADF /thiore-
doxin regardless of the type of nearby cutaneous tumors, suggesting 
the expression of ADF/thioredoxin in relation to ultraviolet light 
irradiation. Plasma membrane-associated thioredoxin reductase po-
tently scavenges free radicals [36,37]. Reduced thioredoxin inacti-
vates hydrogen peroxide [38,39] and regulates human tyrosinase by 
allosteric mechanism [40]. These findings stress a critical role of 
thioredoxin reductase and thioredoxin in anti-oxidant defense 
against ultra-violet light. Recently, we showed that rADF has the 
reducing activity of active oxygen species, especially hydrogen per-
oxide [21]. Thus, under stressful circumstances such as ultraviolet 
light irradiation, the ADF/thioredoxin system may function as a 
unique anti-oxidant enzyme system in human epidermis [36]. 
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ANNOUNCEMENT 
The European Hair Research Society (EHRS) meeting will be held in Berlin, October 2-3, 
1992. 
Topics will include the fullowing. 
Basic research: hair and hair keratin, hair follicle and appendages, laboratory models and 
measurements, hair growth, growth control and neoplasia. 
Hair diseases : experimental and clinical research, diagnostic procedures and treatment, mea-
surement techniques in vivo, new developments. 
Hair as an indicator of internal diseases, drug effects, malignancy, and hormonal disorders, 
etc. 
Hair care and beautification: shampoos, dyes, cosmetic products, etc., topical treatment, 
systemic treatment. 
Hair transplantation: instruments, techniques. 
The Congress C hairman is Prof. Dr. Med. Prof. Dr. h . c. C. E. Orfanos. The Congress 
Secretaries are Dr. U. Blume (tel. 030-798 2819) and Dr. F.-M. Schaart (tel. 030-798 2812). 
The Congress Secretariat can be reached at Department of Dermatology, University Medical 
Center Steglitz, The Free University of Berlin, Hindenburgdamm 30, D-1000 Berlin 45; tel, 
030/798-2808; telex, 184873 uklin; fax, 030/798-4141. 
The official language of the meeting will be English (simultaneous translation into German 
will be provided). 
Deadline for Abstracts is June 30, 1992 (for Short Communications and Posters). 
